Tairen Capital’s DexCom DXCM Stock Holding History

Tairen Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-117,684	Closed	-$4.39M	–	30
2019 Q3	$4.39M	Sell	117,684 -46,716	-28%	-$1.81M	0.65%	32
2019 Q2	$6.16M	Buy	+164,400	New	+$5.17M	1.19%	14

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Tairen Capital's DXCM Position: Q4 2019 in Review

Tairen Capital sold out of DexCom (DXCM) in Q4 2019, closing a stake of 117,684 shares — an estimated $4.39M sold.

Tairen Capital first reported a position in DXCM in Q2 2019 and held it in 2 quarters. The position peaked at $6.16M in Q2 2019. 509 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

Tairen Capital reported no remaining DexCom position as of Q4 2019 after selling out during the quarter.
Tairen Capital sold 117,684 DexCom shares in Q4 2019, an estimated $4.39M.
Tairen Capital first reported a position in DexCom in Q2 2019 and held it in 2 quarters.
Tairen Capital's DexCom position peaked at $6.16M in Q2 2019.
509 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Tairen Capital's 13F filing for Q4 2019, filed 14 Feb 2020.